BRAF and Lynch syndrome: In light of the low rate of BRAF mutations among Middle Easterners, the current recommended algorithm for Lynch syndrome screening in Western countries may be less cost-effective in Middle Eastern populations, in which immediate recourse to germline testing following a demonstration of MMR deficiency may be more cost-efficient than first testing for BRAF mutations.